HomeBiotech

Biotech

CANbridge to Participate in Two Investor Conferences in September

CANbridge to Participate in Two Investor Conferences in September

September 6, 2023

Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials

Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials

September 6, 2023

IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events

IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events

September 5, 2023

Asia Organoids and Organ-on-a-Chip Conference 2023: Explore the Intersection of Technology and Healthcare (Tokyo, Japan – October 5-6, 2023)

Asia Organoids and Organ-on-a-Chip Conference 2023: Explore the Intersection of Technology and Healthcare (Tokyo, Japan – October 5-6, 2023)

September 5, 2023

Tackling the Global Epidemic: Drug of Abuse Testing Market Set to Reach $8 Billion by 2030

Tackling the Global Epidemic: Drug of Abuse Testing Market Set to Reach $8 Billion by 2030

September 5, 2023

Alchemab Therapeutics CEO to Present at Wells Fargo 2023 Healthcare Conference

Alchemab Therapeutics CEO to Present at Wells Fargo 2023 Healthcare Conference

September 5, 2023

iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

September 4, 2023

Biotech & Pharma 4.0 Smart Manufacturing: The Futuristic Approach

Biotech & Pharma 4.0 Smart Manufacturing: The Futuristic Approach

September 2, 2023

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 2, 2023

FDA Roundup: September 1, 2023

FDA Roundup: September 1, 2023

September 2, 2023

« 1 … 38 39 40 41 42 … 75 »